Canada To Ship Experimental Ebola Vaccine To WHO

Canada has planned to ship 800 vials of its Ebola vaccine to the World Health Organization (WHO) in Geneva to curb the outbreak of the disease. The experimental vaccines will be distributed by WHO in the countries most affected by the disease, the Public Health Agency of Canada announced. "The vaccine is undergoing clinical trials on humans at Walter Reed Army Institute of Research in the United States after showing promising results in animal testing," the agency explained. As the vaccine is experimental, researchers are not able to predict how many people could be immunized or treated. The vaccine was developed at Canada's National Microbiology Laboratory in Winnipeg, Manitoba. More than 4,500 people, most of them in the West African countries, had lost their lives to Ebola which was first confirmed in March.